CD79A and COVID-19: The patients included were between the ages of 1 month old and 18 years old, with the diagnosis of COVID-19, confirmed by RT-PCR, from nasopharyngeal and oropharyngeal swabs, tracheal aspirates, or blood serology for the detection of IgA/IgM/IgG antibodies.